Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07220148 · ClinicalTrials.gov registry record · NA
Multimodal Immune and Neuroendocrine Assessment in Drinkers
A NA study, sponsored by Auburn University.
- Not yet
- Registry status
- NA
- Development phase
- 234
- Enrollment target
NCT07220148 is a NA study that has not yet begun recruiting, run by Auburn University. The registered enrollment target is 234 participants.
The verdict
NCT07220148, a NA study, has not yet begun recruiting, sponsored by Auburn University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 234 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to better understand how blood flow in the brain, levels of the hormone, cortisol, and levels of an immune factor, interleukin-6, change in response to pictures of alcohol versus water pictures of water in healthy people who regularly consume alcohol. Researchers will learn about how the brain processes our environment and how it relates to people's drinking behaviors. This information is important because it may allow us to develop new treatments for Alcohol Use Disorders. Participants will be asked to fill out psychological questionnaires at the first appointment. Then, they will do MRI scans with blood draws at visits 2-6. After each MRI scan, participants will undergo the Alcohol Taste Test, which involves drinking beer. There will be a total of 3 visits at baseline, 2 visits one year later, and 2 visits one year after that. Each visit will last 2 hours. Each year, participants will do 21 days of surveys on a smart phone (4 surveys a day; each survey takes less than 2 minutes). The total time commitment for the entire study will be 23 hours.
Interventions
- BEHAVIORAL Alcohol Cue Reactivity and Laboratory Alcohol Administration Paradigm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 234 participants |
| Start Date | 2026-04 |
| Est. Completion | 2031-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07220148
The ClinicalTrials.gov registry entry for NCT07220148 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 234 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Auburn University, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Alcohol Cue Reactivity and Laboratory Alcohol Administration Paradigm is the first listed.
NCT07220148 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07220148 about?
NCT07220148 is a clinical study titled "Multimodal Immune and Neuroendocrine Assessment in Drinkers". The goal of this clinical trial is to better understand how blood flow in the brain, levels of the hormone, cortisol, and levels of an immune factor, interleukin-6, change in response to pictures of alcohol versus water pictures of water in healthy people who regularly consume alcohol. Researchers w...
What is the current status of trial NCT07220148?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 234 participants. The study started on 2026-04. Estimated completion is 2031-12.
What interventions are being tested in trial NCT07220148?
The interventions under investigation include: Alcohol Cue Reactivity and Laboratory Alcohol Administration Paradigm (BEHAVIORAL).
Who is sponsoring clinical trial NCT07220148?
This trial is sponsored by Auburn University, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.